Reference | </br>1: Bircsak KM, Gupta V, Yuen PY, Gorczyca L, Weinberger BI, Vetrano AM, Aleksunes</br> LM. Genetic and Dietary Regulation of Glyburide Efflux by the Human Placental</br> BCRP Transporter. J Pharmacol Exp Ther. 2016 Feb 5. pii: jpet.115.230185. [Epub</br> ahead of print] PubMed PMID: 26850786.</br>2: Sheth KN, Elm JJ, Beslow LA, Sze GK, Kimberly WT. Glyburide Advantage in</br> Malignant Edema and Stroke (GAMES-RP) Trial: Rationale and Design. Neurocrit</br> Care. 2016 Feb;24(1):132-9. doi: 10.1007/s12028-015-0189-7. PubMed PMID:</br> 26268138.</br>3: Harper LM, Glover AV, Biggio JR, Tita A. Predicting failure of glyburide</br> therapy in gestational diabetes. J Perinatol. 2016 Jan 21. doi:</br> 10.1038/jp.2015.216. [Epub ahead of print] PubMed PMID: 26796130.</br>4: Samala S, Veeresham C. Pharmacokinetic and Pharmacodynamic Interaction of</br> Boswellic Acids and Andrographolide with Glyburide in Diabetic Rats: Including</br> Its PK/PD Modeling. Phytother Res. 2016 Jan 13. doi: 10.1002/ptr.5556. [Epub</br> ahead of print] PubMed PMID: 26762235.</br>5: Sheth KN, Simard JM, Elm J, Kronenberg G, Kunte H, Kimberly WT. Human Data</br> Supporting Glyburide in Ischemic Stroke. Acta Neurochir Suppl. 2016;121:13-8.</br> doi: 10.1007/978-3-319-18497-5_3. PubMed PMID: 26463916.</br>6: Glover AV, Tita A, Biggio JR, Harper LM. Examining the Starting Dose of</br> Glyburide in Gestational Diabetes. Am J Perinatol. 2016 Jan;33(2):214-20. doi:</br> 10.1055/s-0035-1564063. Epub 2015 Sep 14. PubMed PMID: 26368915.</br>7: Rezai S, Vielman M, Henderson CE. Glyburide vs Insulin and Adverse Pregnancy</br> Outcomes. JAMA Pediatr. 2015 Oct;169(10):974-5. doi:</br> 10.1001/jamapediatrics.2015.1808. PubMed PMID: 26437012.</br>8: Clemens KK, McArthur E, Dixon SN, Fleet JL, Hramiak I, Garg AX. The</br> hypoglycemic risk of glyburide (glibenclamide) compared with modified-release</br> gliclazide. Can J Diabetes. 2015 Nov;39 Suppl 4:32-40. doi:</br> 10.1016/j.jcjd.2015.09.087. PubMed PMID: 26541489.</br>9: Tuccori M, Wu JW, Yin H, Majdan A, Azoulay L. The Use of Glyburide Compared</br> With Other Sulfonylureas and the Risk of Cancer in Patients With Type 2 Diabetes.</br> Diabetes Care. 2015 Nov;38(11):2083-9. doi: 10.2337/dc15-1358. Epub 2015 Sep 4.</br> PubMed PMID: 26341130.</br>10: Castillo WC, Funk MJ. Glyburide vs Insulin and Adverse Pregnancy</br> Outcomes–Reply. JAMA Pediatr. 2015 Oct;169(10):975. doi:</br> 10.1001/jamapediatrics.2015.1811. PubMed PMID: 26437013.</br>11: Feghali MN, Scifres CM, Caritis SN. Glyburide vs Insulin and Adverse</br> Pregnancy Outcomes. JAMA Pediatr. 2015 Oct;169(10):974. doi:</br> 10.1001/jamapediatrics.2015.1805. PubMed PMID: 26437011.</br>12: Casey BM, Duryea EL, Abbassi-Ghanavati M, Tudela CM, Shivvers SA, McIntire</br> DD, Leveno KJ. Glyburide in Women With Mild Gestational Diabetes: A Randomized</br> Controlled Trial. Obstet Gynecol. 2015 Aug;126(2):303-9. doi:</br> 10.1097/AOG.0000000000000967. PubMed PMID: 26241419.</br>13: Clemens KK, McArthur E, Dixon SN, Fleet JL, Hramiak I, Garg AX. The</br> Hypoglycemic Risk of Glyburide (Glibenclamide) Compared with Modified-Release</br> Gliclazide. Can J Diabetes. 2015 Aug;39(4):308-16. doi:</br> 10.1016/j.jcjd.2015.01.001. Epub 2015 Mar 31. PubMed PMID: 25840942.</br>14: Joy NG, Tate DB, Davis SN. Counterregulatory responses to hypoglycemia differ</br> between glimepiride and glyburide in non diabetic individuals. Metabolism. 2015</br> Jun;64(6):729-37. doi: 10.1016/j.metabol.2015.02.006. Epub 2015 Feb 26. PubMed</br> PMID: 25765720; PubMed Central PMCID: PMC4408247.</br>15: Glyburide, Gliclazide or Glimepiride for Elderly Patients with Type 2</br> Diabetes: A Review of the Clinical Effectiveness and Safety – An Update</br> [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health;</br> 2015 Aug 18. Available from http://www.ncbi.nlm.nih.gov/books/NBK315876/</br> PubMed PMID: 26355189.</br>16: Amin M, Suksomboon N, Poolsup N, Malik O. Comparison of glyburide with</br> metformin in treating gestational diabetes mellitus: a systematic review and</br> meta-analysis. Clin Drug Investig. 2015 Jun;35(6):343-51. doi:</br> 10.1007/s40261-015-0289-3. PubMed PMID: 25985837.</br>17: Jiang S, Zhao W, Chen Y, Zhong Z, Zhang M, Li F, Xu P, Zhao K, Li Y, Liu L,</br> Liu X. Paroxetine decreased plasma exposure of glyburide partly via inhibiting</br> intestinal absorption in rats. Drug Metab Pharmacokinet. 2015 Jun;30(3):240-6.</br> doi: 10.1016/j.dmpk.2015.02.004. Epub 2015 Mar 11. PubMed PMID: 25890690.</br>18: Camelo Castillo W, Boggess K, Stürmer T, Brookhart MA, Benjamin DK Jr,</br> Jonsson Funk M. Association of Adverse Pregnancy Outcomes With Glyburide vs</br> Insulin in Women With Gestational Diabetes. JAMA Pediatr. 2015 May;169(5):452-8. </br> doi: 10.1001/jamapediatrics.2015.74. PubMed PMID: 25822253.</br>19: Holt RI. Glyburide for gestational diabetes: time for a pause for thought.</br> JAMA Pediatr. 2015 May;169(5):427-8. doi: 10.1001/jamapediatrics.2015.144. PubMed</br> PMID: 25821923.</br>20: Zhang X, Wang X, Vernikovskaya DI, Fokina VM, Nanovskaya TN, Hankins GD,</br> Ahmed MS. Quantitative determination of metformin, glyburide and its metabolites </br> in plasma and urine of pregnant patients by LC-MS/MS. Biomed Chromatogr. 2015</br> Apr;29(4):560-9. doi: 10.1002/bmc.3314. Epub 2014 Aug 27. PubMed PMID: 25164921; </br> PubMed Central PMCID: PMC4344438.</br></br>
|